The company
Heartbeam, Inc.
BEAT · Nasdaq
BEAT stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 38 weeks. It is 41.9% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 38
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $1.9M
- Insider sales, 12 months
- $1.1M
- Officials’ trades on record
- 0
- Institutions holding
- 42 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mark E. StromeDirector | bought | 750,000at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Marga Ortigas-WedekindDirector | bought | 25,000at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Robert Paul EnoPresident | bought | 12,500at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Richard FerrariDirector | bought | 62,500at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Branislav VajdicDirector | bought | 31,250at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Michael R. JaffDirector | bought | 31,250at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Willem ElfrinkDirector | bought | 187,500at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Tim CruickshankCFO | bought | 31,250at $0.80 | 16 Apr 2026filed 16 Apr 2026 |
| Richard FerrariDirector | bought | 57,500at $0.80 | 16 Apr 2026filed 24 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,137,512$1.6M | +939,719+78.5% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 987,837$741K | +89,516+10.0% |
| CORSAIR CAPITAL MANAGEMENT, L.P.new · filed 14 Aug 2026 | 912,500$684K | +912,500 |
| Bleichroeder LPnew · filed 13 Aug 2026 | 625,000$469K | +625,000 |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 479,386$360K | +102,174+27.1% |
| Smith Salley Wealth Managementunchanged · filed 23 Jul 2026 | 367,647$276K | 00.0% |
| UBS Group AGreduced · filed 13 Aug 2026 | 298,917$224K | -36,272−10.8% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 274,818$206K | +124,756+83.1% |
| Sigma Planning Corpadded · filed 7 Aug 2026 | 247,700$186K | +115,150+86.9% |
| Beacon Pointe Advisors, LLCreduced · filed 18 Aug 2026 | 247,058$185K | -400−0.2% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.